Diseases, Conditions, Syndromes

Q&A: Will we have a 'tripledemic' this year?

There's a chill in the air, students are back in school and summer's colors are fading—cold and flu season is nearly upon us.

Oncology & Cancer

Adjuvant durvalumab extends survival in small cell lung cancer

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to a study published online Sept. 13 in the New England ...

page 3 from 10